PL2344495T3 - Tricykliczne związki oksazolidynowe jako antybiotyki - Google Patents

Tricykliczne związki oksazolidynowe jako antybiotyki

Info

Publication number
PL2344495T3
PL2344495T3 PL09740759T PL09740759T PL2344495T3 PL 2344495 T3 PL2344495 T3 PL 2344495T3 PL 09740759 T PL09740759 T PL 09740759T PL 09740759 T PL09740759 T PL 09740759T PL 2344495 T3 PL2344495 T3 PL 2344495T3
Authority
PL
Poland
Prior art keywords
antibiotic compounds
oxazolidinone antibiotic
tricyclic
tricyclic oxazolidinone
compounds
Prior art date
Application number
PL09740759T
Other languages
English (en)
Inventor
Christian Hubschwerlen
Daniel Ritz
Georg Rueedi
Jean-Philippe Surivet
Acklin Cornelia Zumbrunn
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41402623&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2344495(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of PL2344495T3 publication Critical patent/PL2344495T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL09740759T 2008-10-07 2009-10-06 Tricykliczne związki oksazolidynowe jako antybiotyki PL2344495T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IB2008054109 2008-10-07
IB2009051059 2009-03-13
IB2009052843 2009-06-30
EP09740759.7A EP2344495B1 (en) 2008-10-07 2009-10-06 Tricyclic oxazolidinone antibiotic compounds
PCT/IB2009/054357 WO2010041194A1 (en) 2008-10-07 2009-10-06 Tricyclic oxazolidinone antibiotic compounds

Publications (1)

Publication Number Publication Date
PL2344495T3 true PL2344495T3 (pl) 2015-06-30

Family

ID=41402623

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09740759T PL2344495T3 (pl) 2008-10-07 2009-10-06 Tricykliczne związki oksazolidynowe jako antybiotyki

Country Status (25)

Country Link
US (3) US8618092B2 (pl)
EP (1) EP2344495B1 (pl)
JP (1) JP4833385B1 (pl)
KR (1) KR101294962B1 (pl)
CN (3) CN104151316B (pl)
AR (1) AR073774A1 (pl)
AU (1) AU2009302075B2 (pl)
BR (1) BRPI0920895A8 (pl)
CA (1) CA2739373C (pl)
CY (1) CY1116155T1 (pl)
DK (1) DK2344495T3 (pl)
ES (1) ES2533217T3 (pl)
HR (1) HRP20150370T1 (pl)
IL (1) IL212139A (pl)
MA (1) MA32768B1 (pl)
MX (1) MX2011003370A (pl)
MY (1) MY158520A (pl)
NZ (1) NZ592642A (pl)
PL (1) PL2344495T3 (pl)
PT (1) PT2344495E (pl)
RU (1) RU2530884C2 (pl)
SI (1) SI2344495T1 (pl)
TW (1) TWI415853B (pl)
WO (1) WO2010041194A1 (pl)
ZA (1) ZA201103332B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201309689A (zh) 2011-02-07 2013-03-01 Daiichi Sankyo Co Ltd 含胺基之吡咯啶酮衍生物
KR20130002712A (ko) 2011-06-29 2013-01-08 현대자동차주식회사 하이브리드 자동차의 파워트레인 제어방법
CA2840611A1 (en) * 2011-06-30 2013-01-03 Dsm Ip Assets B.V. Silicone-containing monomer
WO2013021363A1 (en) 2011-08-11 2013-02-14 Actelion Pharmaceuticals Ltd Quinazoline-2,4-dione derivatives
IN2014CN04126A (pl) 2011-11-08 2015-07-10 Actelion Pharmaceuticals Ltd
TW201326180A (zh) 2011-11-30 2013-07-01 Actelion Pharmaceuticals Ltd ３，７－二取代八氫－２Ｈ－吡啶并［４，３－ｅ］［１，３］□嗪－２－酮抗生素
WO2014024056A1 (en) 2012-08-06 2014-02-13 Daiichi Sankyo Company, Limited Pyrrolidine derivatives with antibacterial properties
WO2014108832A1 (en) 2013-01-09 2014-07-17 Actelion Pharmaceuticals Ltd Antibacterial oxazolone derivatives
JP2016504408A (ja) 2013-01-09 2016-02-12 アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ 抗菌活性を有するオキサジアゾロン誘導体
MA38588B1 (fr) 2013-04-16 2018-04-30 Idorsia Pharmaceuticals Ltd Dérivés bi-aromatiques antibactériens
WO2014181266A1 (en) 2013-05-08 2014-11-13 Actelion Pharmaceuticals Ltd Antibacterial phthalide derivatives
AR102256A1 (es) 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
UY36851A (es) * 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
RU2602503C1 (ru) * 2015-09-23 2016-11-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СПХФА) Трициклические соединения, обладающие противобактериальной активностью, способ их получения и содержащее их фармацевтическое средство
WO2017113288A1 (en) * 2015-12-31 2017-07-06 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
AR108108A1 (es) 2016-04-14 2018-07-18 Idorsia Pharmaceuticals Ltd Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
US10912780B2 (en) 2017-06-08 2021-02-09 Bugworks Research, Inc. Heterocyclic compounds useful as anti-bacterial agents and method for production thereof
CN111527093B (zh) * 2017-11-29 2023-06-09 巴格沃克斯研究有限公司 抗菌杂环化合物及其合成

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1394373A (en) * 1972-05-17 1975-05-14 Pfizer Ltd Control of plant diseases
IT1212552B (it) 1982-10-20 1989-11-30 Italo Britannica L Manet Ti H Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica
US5298518A (en) * 1989-09-29 1994-03-29 Eisai Co., Ltd. Biphenylmethane derivative and pharmacological use
US5254682A (en) 1989-12-08 1993-10-19 Merck & Co., Inc. Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs
CZ141399A3 (cs) 1996-10-24 1999-07-14 Novartis Ag Substituované aminoalkanfosfonové kyseliny, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
DE19805117A1 (de) 1998-02-09 1999-08-12 Bayer Ag Neue Oxazolidinone mit azolhaltigen Tricyclen
GB9822450D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
AU1026901A (en) 1999-10-29 2001-05-08 Syngenta Participations Ag Novel herbicides
CN1452619A (zh) 2000-07-26 2003-10-29 史密斯克莱·比奇曼公司 具有抗细菌活性的氨基哌啶喹啉和它们的氮杂等排的类似物
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
AR042486A1 (es) 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
GB0229522D0 (en) * 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
WO2005019177A1 (en) 2003-08-14 2005-03-03 Icos Corporation Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
GB0408308D0 (en) 2004-04-14 2004-05-19 Vectura Ltd Pharmaceutical compositions
BRPI0514381A (pt) 2004-07-30 2008-06-10 Palumed Sa compostos hìbridos de aminoquinolina-antibiótico, composições farmacêuticas, método de preparação e uso destes
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
JP4887297B2 (ja) 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質
US20100286211A1 (en) * 2004-10-08 2010-11-11 Biswajit Das Oxazolidinone derivatives as antimicrobials
JP5314244B2 (ja) 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
KR20080016577A (ko) 2005-05-24 2008-02-21 아스트라제네카 아베 항균 활성을 갖는 아미노피페리딘 퀴놀린 및 이들의아자이소스테릭 유사체
GB0511190D0 (en) 2005-06-01 2005-07-06 Sterix Ltd Use
WO2007016610A2 (en) 2005-08-02 2007-02-08 Glaxo Group Limited Antibacterial agents
HRP20100194T8 (hr) * 2005-10-21 2010-06-30 Glaxo Group Limited Perikondenzirani triciklički spojevi, korisni kao antibakterijska sredstva
WO2007071936A1 (en) * 2005-12-22 2007-06-28 Glaxo Group Limited Heterocyclic compounds, their preparation and their use as antibacterials
ES2331930T3 (es) 2006-02-14 2010-01-20 Pfizer Products Inc. Oxazolidinonas con benzoxazinonas y benzoxazepinonas como agentes antibacterianos.
DE602007006927D1 (en) 2006-03-23 2010-07-15 Actelion Pharmaceuticals Ltd Antibiotische cyclohexyl- oder piperidinylcarboxamid-derivate
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
EP2404912A3 (en) 2006-06-16 2012-07-25 Pharma Mar S.A. Process and intermediates for the preparation of antitumoral dihydropyran-2-one compounds
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
TW200819457A (en) 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
WO2008066899A2 (en) 2006-11-28 2008-06-05 Marinus Pharmaceuticals Nanoparticulate formulations and methods for the making and use thereof
ATE495743T1 (de) 2006-12-01 2011-02-15 Galapagos Nv Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
CL2007003693A1 (es) 2006-12-22 2008-06-27 Actelion Pharmaceuticals Ltd Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
GB0705672D0 (en) 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds
EP2141154A4 (en) * 2007-03-30 2011-06-01 Inst Med Molecular Design Inc OXAZOLIDINONE DERIVATIVITY WITH HEMMETIC EFFECT ON TYPE I 11-HYDROXYSTEROIDDEHYDROGENASE
WO2008120003A1 (en) 2007-04-03 2008-10-09 Astrazeneca Ab Substituted piperidines for use in the treatment of bacterial infections
CL2008001003A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
EP1980251A1 (en) 2007-04-13 2008-10-15 Glaxo Group Limited Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis
PT2137196E (pt) 2007-04-20 2010-12-16 Glaxo Group Ltd Compostos tricíclicos contendo azoto como agentes antibacterianos
GB0707706D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
GB0707708D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
EP2154965A4 (en) 2007-05-29 2011-08-17 Glaxosmithkline Llc NAPHTHYRIDINE DERIVATIVES AS P13 KINASE INHIBITORS
AR066879A1 (es) 2007-06-08 2009-09-16 Novartis Ag Derivados de quinoxalina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus
CA2689102C (en) 2007-06-15 2016-07-26 Actelion Pharmaceuticals Ltd 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
EP2005995A1 (en) 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
JP5323088B2 (ja) 2007-12-18 2013-10-23 アクテリオン ファーマシューティカルズ リミテッド ５−アミノシクリルメチル−オキサゾリジン−２−オン誘導体
GB0800367D0 (en) 2008-01-09 2008-02-20 Glaxo Group Ltd Compounds
BRPI0907892A2 (pt) * 2008-02-20 2015-07-28 Actelion Pharmaceuticals Ltd Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo
CA2713187C (en) 2008-02-22 2016-06-07 Actelion Pharmaceuticals Ltd Oxazolidinone derivatives
TWI426683B (zh) * 2009-03-17 2014-02-11 Vasstek Int Corp A voice coil motor with a flat coil
TW201103661A (en) * 2009-07-17 2011-02-01 chao-qin Shi Manufacturing method of tooth-type restraint belt (II)
IN2014CN04126A (pl) 2011-11-08 2015-07-10 Actelion Pharmaceuticals Ltd
JP2016504408A (ja) 2013-01-09 2016-02-12 アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ 抗菌活性を有するオキサジアゾロン誘導体
MA38588B1 (fr) 2013-04-16 2018-04-30 Idorsia Pharmaceuticals Ltd Dérivés bi-aromatiques antibactériens
WO2014181266A1 (en) 2013-05-08 2014-11-13 Actelion Pharmaceuticals Ltd Antibacterial phthalide derivatives

Also Published As

Publication number Publication date
US20110195961A1 (en) 2011-08-11
US9346804B2 (en) 2016-05-24
RU2011117412A (ru) 2012-11-20
CN104151315A (zh) 2014-11-19
CN104151316A (zh) 2014-11-19
ES2533217T3 (es) 2015-04-08
KR20110063836A (ko) 2011-06-14
CN102164925A (zh) 2011-08-24
HRP20150370T1 (hr) 2015-05-08
US8618092B2 (en) 2013-12-31
WO2010041194A1 (en) 2010-04-15
MY158520A (en) 2016-10-14
MA32768B1 (fr) 2011-11-01
MX2011003370A (es) 2011-04-28
EP2344495A1 (en) 2011-07-20
AR073774A1 (es) 2010-12-01
ZA201103332B (en) 2012-10-31
US20160237088A1 (en) 2016-08-18
EP2344495B1 (en) 2014-12-31
PT2344495E (pt) 2015-04-01
SI2344495T1 (sl) 2015-03-31
US9822114B2 (en) 2017-11-21
CY1116155T1 (el) 2017-02-08
CN102164925B (zh) 2015-04-08
DK2344495T3 (en) 2015-02-02
BRPI0920895A2 (pt) 2015-12-22
KR101294962B1 (ko) 2013-08-12
IL212139A (en) 2016-07-31
TW201018697A (en) 2010-05-16
BRPI0920895A8 (pt) 2017-12-26
JP4833385B1 (ja) 2011-12-07
US20140142093A1 (en) 2014-05-22
CN104151316B (zh) 2016-06-15
JP2012505199A (ja) 2012-03-01
RU2530884C2 (ru) 2014-10-20
HK1159611A1 (en) 2012-08-03
AU2009302075A1 (en) 2010-04-15
TWI415853B (zh) 2013-11-21
NZ592642A (en) 2012-11-30
CN104151315B (zh) 2017-01-11
AU2009302075B2 (en) 2015-04-16
CA2739373A1 (en) 2010-04-15
IL212139A0 (en) 2011-06-30
CA2739373C (en) 2017-01-24

Similar Documents

Publication Publication Date Title
IL212139A0 (en) Tricyclic oxazolidinone antibiotic compounds
SI2299821T1 (sl) Triciklične spojine
IL253516B (en) tricyclic compounds
PL2146987T3 (pl) Pochodne oksazolidynonu jako antybiotyki
PL2915813T3 (pl) Antybiotyki oksazolidynonowe
IL213325A0 (en) Antibacterial compounds
IL220053A0 (en) Novel tricyclic compounds
EP1988091A4 (en) TRICYCLIC CONNECTIONS
IL200009A0 (en) Macrocyclic compound
PL2513115T3 (pl) Antybiotyki tricykliczne
ZA201202350B (en) Antibiotic compounds
EP2370440A4 (en) NEW COMPOUNDS
EP2327690A4 (en) TRICYCLIC CONNECTION
GB0800411D0 (en) Novel compounds
HK1173156A (en) Antibiotic compounds
HK1174787A (en) Novel tricyclic compounds
GB0802008D0 (en) Novel compounds
GB0801327D0 (en) Novel compounds
GB0802677D0 (en) Novel compounds
GB0800679D0 (en) Novel compounds
GB0800839D0 (en) Novel compounds
GB0820491D0 (en) Compounds